1. The synergistic anti-tumor effect of schisandrin B and apatinib.
- Author
-
Li, Ya-Jing, Liu, Hong-Tao, Xue, Chao-Jun, Xing, Xiao-Qin, Dong, Song-Tao, Wang, Lin-Shan, Ding, Cong-Yang, Meng, Lu, and Dong, Zhan-Jun
- Subjects
- *
CELL proliferation , *ANTINEOPLASTIC agents , *APOPTOSIS , *CELL culture , *CELL lines , *CELL migration , *CELL physiology , *COLORIMETRY , *FLOW cytometry , *GENE expression , *MICROBIOLOGICAL assay , *MOLECULAR structure , *STOMACH tumors , *WESTERN immunoblotting , *WOUND healing , *PLANT extracts , *PROTEIN-tyrosine kinase inhibitors , *DISEASE progression , *CASPASES , *MATRIX metalloproteinases , *IN vitro studies , *ONE-way analysis of variance , *PHARMACODYNAMICS - Abstract
The synergistic anti-tumor effect of schisandrin B (Sch.B) and apatinib was investigated in vitro. The CCK-8 assay revealed that Sch.B enhanced the inhibition of apatinib on cell proliferation by arresting cell cycle in G0/G1 phase. Sch.B also potentiated the suppression of apatinib on cell migration and invasion, by means of wound-healing and transwell invasion assay. Flow cytometry results showed that Sch.B enhanced apoptosis induced by apatinib. The results were confirmed by western blot analysis of the proteins MMP-9, and Bax caspase-9, and -12. These results suggest that combining apatinib and Sch.B is an effective therapeutic strategy for preventing GC progression. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF